This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.
We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.
Oxford, U.K. May 19,2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the Clinical AI technology company, today announces the US launch of its web-based COVID-19 focused software application called CVm-Health™ - the ‘Good Neighbor’ app. CVm-Health was successfully rolled out in the UK in April 2020.
Today’s launch of CVm-Health in the US coincides with the start of the Microsoft Build conference, where the app will be highlighted https://youtu.be/FIOPM6TiOmg
The app is free to use for anyone in the US and provides a secure way for individuals to manage their health by recording their vital signs daily and any COVID-19 related symptoms.
The app also enables individuals to help family and friends who are digitally disconnected and at risk from coronavirus to monitor their health. In 2019 the Pew Research Center found that 10% of all Americans and 27% of Americans over 65 don’t use the internet, and many of these people are in higher-risk categories for COVID-19.
Subject to individuals consent, data generated by the application will be de-identified and analyzed using sophisticated machine learning techniques to derive insights that will be made available for medical research into the prevention, diagnosis and treatment of COVID-19.
The app was developed with the support of Cognizant and Microsoft. Sensyne announced its partnership with Cognizant in October 2019 to accelerate the development of its applications specifically for the US market. Microsoft is Sensyne’s chosen provider of world-class IT infrastructure services, including its Azure® suite of cloud services, which enable Sensyne’s clinical applications to be scaled globally.
Lord (Paul) Drayson, CEO of Sensyne Health, said:
"We wanted to provide an app that helped everyone to record and self-monitor their symptoms and take control of their own health, as well as helping others.”
Oxford, U.K. May 19,2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the Clinical AI technology company, today announces the US launch of its web-based COVID-19 focused software application called CVm-Health™ - the ‘Good Neighbor’ app. CVm-Health was successfully rolled out in the UK in April 2020.
Today’s launch of CVm-Health in the US coincides with the start of the Microsoft Build conference, where the app will be highlighted https://youtu.be/FIOPM6TiOmg
The app is free to use for anyone in the US and provides a secure way for individuals to manage their health by recording their vital signs daily and any COVID-19 related symptoms.
The app also enables individuals to help family and friends who are digitally disconnected and at risk from coronavirus to monitor their health. In 2019 the Pew Research Center found that 10% of all Americans and 27% of Americans over 65 don’t use the internet, and many of these people are in higher-risk categories for COVID-19.
Subject to individuals consent, data generated by the application will be de-identified and analyzed using sophisticated machine learning techniques to derive insights that will be made available for medical research into the prevention, diagnosis and treatment of COVID-19.
The app was developed with the support of Cognizant and Microsoft. Sensyne announced its partnership with Cognizant in October 2019 to accelerate the development of its applications specifically for the US market. Microsoft is Sensyne’s chosen provider of world-class IT infrastructure services, including its Azure® suite of cloud services, which enable Sensyne’s clinical applications to be scaled globally.
Lord (Paul) Drayson, CEO of Sensyne Health, said:
"We wanted to provide an app that helped everyone to record and self-monitor their symptoms and take control of their own health, as well as helping others.”
Oxford, U.K. May 19,2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the Clinical AI technology company, today announces the US launch of its web-based COVID-19 focused software application called CVm-Health™ - the ‘Good Neighbor’ app. CVm-Health was successfully rolled out in the UK in April 2020.
Today’s launch of CVm-Health in the US coincides with the start of the Microsoft Build conference, where the app will be highlighted https://youtu.be/FIOPM6TiOmg
The app is free to use for anyone in the US and provides a secure way for individuals to manage their health by recording their vital signs daily and any COVID-19 related symptoms.
The app also enables individuals to help family and friends who are digitally disconnected and at risk from coronavirus to monitor their health. In 2019 the Pew Research Center found that 10% of all Americans and 27% of Americans over 65 don’t use the internet, and many of these people are in higher-risk categories for COVID-19.
Subject to individuals consent, data generated by the application will be de-identified and analyzed using sophisticated machine learning techniques to derive insights that will be made available for medical research into the prevention, diagnosis and treatment of COVID-19.
The app was developed with the support of Cognizant and Microsoft. Sensyne announced its partnership with Cognizant in October 2019 to accelerate the development of its applications specifically for the US market. Microsoft is Sensyne’s chosen provider of world-class IT infrastructure services, including its Azure® suite of cloud services, which enable Sensyne’s clinical applications to be scaled globally.
Lord (Paul) Drayson, CEO of Sensyne Health, said:
"We wanted to provide an app that helped everyone to record and self-monitor their symptoms and take control of their own health, as well as helping others.”
Oxford, U.K. May 19,2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the Clinical AI technology company, today announces the US launch of its web-based COVID-19 focused software application called CVm-Health™ - the ‘Good Neighbor’ app. CVm-Health was successfully rolled out in the UK in April 2020.
Today’s launch of CVm-Health in the US coincides with the start of the Microsoft Build conference, where the app will be highlighted https://youtu.be/FIOPM6TiOmg
The app is free to use for anyone in the US and provides a secure way for individuals to manage their health by recording their vital signs daily and any COVID-19 related symptoms.
The app also enables individuals to help family and friends who are digitally disconnected and at risk from coronavirus to monitor their health. In 2019 the Pew Research Center found that 10% of all Americans and 27% of Americans over 65 don’t use the internet, and many of these people are in higher-risk categories for COVID-19.
Subject to individuals consent, data generated by the application will be de-identified and analyzed using sophisticated machine learning techniques to derive insights that will be made available for medical research into the prevention, diagnosis and treatment of COVID-19.
The app was developed with the support of Cognizant and Microsoft. Sensyne announced its partnership with Cognizant in October 2019 to accelerate the development of its applications specifically for the US market. Microsoft is Sensyne’s chosen provider of world-class IT infrastructure services, including its Azure® suite of cloud services, which enable Sensyne’s clinical applications to be scaled globally.
Lord (Paul) Drayson, CEO of Sensyne Health, said:
"We wanted to provide an app that helped everyone to record and self-monitor their symptoms and take control of their own health, as well as helping others.”
Oxford, U.K. May 19,2020: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the Clinical AI technology company, today announces the US launch of its web-based COVID-19 focused software application called CVm-Health™ - the ‘Good Neighbor’ app. CVm-Health was successfully rolled out in the UK in April 2020.
Today’s launch of CVm-Health in the US coincides with the start of the Microsoft Build conference, where the app will be highlighted https://youtu.be/FIOPM6TiOmg
The app is free to use for anyone in the US and provides a secure way for individuals to manage their health by recording their vital signs daily and any COVID-19 related symptoms.
The app also enables individuals to help family and friends who are digitally disconnected and at risk from coronavirus to monitor their health. In 2019 the Pew Research Center found that 10% of all Americans and 27% of Americans over 65 don’t use the internet, and many of these people are in higher-risk categories for COVID-19.
Subject to individuals consent, data generated by the application will be de-identified and analyzed using sophisticated machine learning techniques to derive insights that will be made available for medical research into the prevention, diagnosis and treatment of COVID-19.
The app was developed with the support of Cognizant and Microsoft. Sensyne announced its partnership with Cognizant in October 2019 to accelerate the development of its applications specifically for the US market. Microsoft is Sensyne’s chosen provider of world-class IT infrastructure services, including its Azure® suite of cloud services, which enable Sensyne’s clinical applications to be scaled globally.
Lord (Paul) Drayson, CEO of Sensyne Health, said:
"We wanted to provide an app that helped everyone to record and self-monitor their symptoms and take control of their own health, as well as helping others.”